59 results
8-K
EX-10.1
NMTRQ
9 Meters Biopharma, Inc.
6 Oct 22
Entry into a Material Definitive Agreement
4:15pm
. The provisions of this Section 6.13(b) shall survive the expiration or earlier termination of this Lease with respect to any injury, illness, death or damage … the expiration or earlier termination of this Lease with respect to any injury, illness, death or damage occurring prior to such expiration or termination
8-K
EX-99.2
NMTRQ
9 Meters Biopharma, Inc.
30 Jun 22
9 Meters Biopharma Announces Positive Preliminary Results from Phase 2 Study of Vurolenatide in Short Bowel Syndrome
7:06am
Years Post Resection: 40% Cause of Death: Related to PN (22%) Related to Short Bowel (13%) Related to Primary Disease (31%) Other (34%) Diarrhea
8-K
EX-10.2
xd1fpst2cep
22 Jun 22
Departure of Directors or Certain Officers
4:51pm
8-K
4fbdt
22 Jun 22
Departure of Directors or Certain Officers
4:51pm
8-K
EX-10.1
u1m1mi di
22 Jun 22
Departure of Directors or Certain Officers
4:51pm
8-K
EX-99.2
aqqlp86dg5
19 Jul 21
9 Meters Biopharma, Inc. Announces the Acquisition of Humanized Anti-GIP Monoclonal Antibody from Lobesity
8:36am
8-K
jqcp5nxlq8ixy af6d
23 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:31pm
8-K
EX-10.1
5xg4ooqgxyj xmg6y
30 Jun 20
Departure of Directors or Certain Officers
4:34pm